RecruitingNot ApplicableNCT06346080

Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment


Sponsor

KU Leuven

Enrollment

2,200 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria3

  • Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
  • Access to computer or smartphone
  • Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)

Exclusion Criteria2

  • Individuals less than 18yo and more than 75yo
  • Incarcerated individuals

Interventions

OTHERSurvey

Discrete choice survey


Locations(1)

University Hospitals Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06346080


Related Trials